# Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

- Source: PR Newswire
- Published: 2026-10-24T01:26:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/lunit-and-summit-therapeutics-announce-agreement-to-apply-ai-powered-scope-io-platform-for-tumor-microenvironment-analysis-in-immuno-oncology-development-302918571.html
- Canonical: https://groundlevelnews.com/story/lunit-and-summit-therapeutics-announce-agreement-to-apply-ai-powered-s-669b7e/

Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology SEOUL, South Korea, Oct. 24, 2026 /PRNewswire/ -- Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. (NASDAQ: SMMT) today...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._